Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of and Risk Factors for Cataract in Anterior Uveitis.
Papaliodis GN, Rosner BA, Dreger KA, Fitzgerald TD, Artornsombudh P, Kothari S, Gangaputra SS, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Pak CM, Ying GS, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group. Papaliodis GN, et al. Among authors: dreger ka. Am J Ophthalmol. 2023 Oct;254:221-232. doi: 10.1016/j.ajo.2023.06.021. Epub 2023 Jul 5. Am J Ophthalmol. 2023. PMID: 37414328
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.
Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Kempen JH, et al. Ophthalmic Epidemiol. 2008 Jan-Feb;15(1):47-55. doi: 10.1080/09286580701585892. Ophthalmic Epidemiol. 2008. PMID: 18300089
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.
Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Foster CS; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Kaçmaz RO, et al. Am J Ophthalmol. 2008 Dec;146(6):828-36. doi: 10.1016/j.ajo.2008.06.019. Epub 2008 Aug 16. Am J Ophthalmol. 2008. PMID: 18708181 Free PMC article.
Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.
Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Levin MH, et al. Ophthalmology. 2014 Feb;121(2):588-95.e1. doi: 10.1016/j.ophtha.2013.09.023. Epub 2013 Dec 12. Ophthalmology. 2014. PMID: 24332536 Free PMC article.
Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH; SITE Cohort Research Group. Gangaputra SS, et al. Am J Ophthalmol. 2019 Dec;208:68-75. doi: 10.1016/j.ajo.2019.07.008. Epub 2019 Jul 22. Am J Ophthalmol. 2019. PMID: 31344346 Free PMC article.
Visual Acuity Outcome over Time in Non-Infectious Uveitis.
Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Altaweel MM, Holbrook JT, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Pistilli M, et al. Among authors: dreger ka. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1064-1071. doi: 10.1080/09273948.2019.1687733. Epub 2019 Dec 10. Ocul Immunol Inflamm. 2021. PMID: 31821051 Free PMC article.
Factors Predictive of Remission of Chronic Anterior Uveitis.
Sobrin L, Pistilli M, Dreger K, Kothari S, Khachatryan N, Artornsombudh P, Pujari SS, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Sobrin L, et al. Ophthalmology. 2020 Jun;127(6):826-834. doi: 10.1016/j.ophtha.2019.11.020. Epub 2019 Nov 28. Ophthalmology. 2020. PMID: 31932091 Free PMC article.
Contemporaneous Risk Factors for Visual Acuity in Non-Infectious Uveitis.
Pistilli M, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Kempen JH. Pistilli M, et al. Among authors: dreger ka. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1056-1063. doi: 10.1080/09273948.2020.1828493. Epub 2021 Feb 23. Ocul Immunol Inflamm. 2021. PMID: 33621148
Risk of Cataract in Intermediate Uveitis.
Minkus CL, Pistilli M, Dreger KA, Fitzgerald TD, Payal AR, Begum H, Kaçmaz RO, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Buchanich JM, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group. Minkus CL, et al. Among authors: dreger ka. Am J Ophthalmol. 2021 Sep;229:200-209. doi: 10.1016/j.ajo.2021.02.032. Epub 2021 Mar 10. Am J Ophthalmol. 2021. PMID: 33713679 Free PMC article.
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease.
Gangaputra S, Newcomb C, Armour R, Choi D, Ying GS, Groth S, Begum H, Fitzgerald T, Artornsombudh P, Daniel E, Bhatt N, Foster S, Jabs D, Levy-Clarke G, Nussenblatt R, Rosenbaum JT, Sen HN, Suhler E, Thorne J, Dreger K, Buchanich J, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Gangaputra S, et al. Br J Ophthalmol. 2024 Feb 21;108(3):380-385. doi: 10.1136/bjo-2022-322236. Br J Ophthalmol. 2024. PMID: 36810151
15 results